Catheter Precision (VTAK) Cash & Equivalents (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Cash & Equivalents data on file, last reported at $400000.0 in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 20.0% year-over-year to $400000.0 in Q1 2026; TTM through Mar 2026 was $400000.0, a 20.0% decrease from a year earlier, with the FY2025 full-year figure at $88000.0, down 96.94% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $400000.0, up from $88000.0 in the prior quarter.
• Over the last five years, Cash & Equivalents for VTAK reached as high as $17.7 million in Q1 2022 and fell as low as $16000.0 in Q2 2024.
• Historically, Cash & Equivalents has averaged $5.3 million across 5 years, with a median of $2.2 million in 2024.
• Across the five-year window, Cash & Equivalents sank 99.78% in 2024 and soared 5137.5% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $15.9 million in 2022, then plunged by 77.52% to $3.6 million in 2023, then fell by 19.41% to $2.9 million in 2024, then slumped by 96.94% to $88000.0 in 2025, then surged by 354.55% to $400000.0 in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $400000.0 in Q1 2026, $88000.0 in Q4 2025, and $1.1 million in Q3 2025.